BGLC vs HOLX · rev $99.0K vs P/E 32, rev $4.10B
BioNexus Gene Lab Corp Common stock (BGLC) versus Hologic Inc (HOLX) — a side-by-side from cached financials, not a winner call.
BioNexus Gene Lab Corp Common stock (BGLC) is a specialty chemicals company listed on NASDAQ.
Hologic Inc (HOLX) is a medical instruments & supplies company listed on NASDAQ.
Latest reported BGLC revenue for 2026-06-30 was $99.0K. Net income was -$830.0K. BGLC currently screens at market cap $6.1M.
Latest reported HOLX revenue for 2025-09-27 was $4.10B. Net income was $565.7M. Revenue was up 1.7% from 2024-09-28 to 2025-09-27. HOLX currently screens at market cap $16.97B and trailing P/E 31.5.
BGLC currently screens at market cap $6.1M. HOLX currently screens at market cap $16.97B and trailing P/E 31.5.
Not investment advice. Open the BGLC and HOLX stock pages for the full models.
Not investment advice.